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Autism spectrum disorders (ASDs) comprise a group
of clinical phenotypes characterized by repetitive
behavior and social and communication deficits.
Autism is generally viewed as a neurodevelopmental
disorder where insults during embryonic or early
postnatal periods result in aberrant wiring and func-
tion of neuronal circuits. Neurexins are synaptic
proteins associated with autism. Here, we generated
transgenic bNrx1DCmice in which neurexin function
is selectively impaired during late postnatal stages.
Whole-cell recordings in cortical neurons show an
impairment of glutamatergic synaptic transmission
in the bNrx1DC mice. Importantly, mutant mice
exhibit autism-related symptoms, such as increased
self-grooming, deficits in social interactions, and
altered interaction for nonsocial olfactory cues. The
autistic-like phenotype of bNrx1DC mice can be
reversed after removing the mutant protein in aged
animals. The defects resulting from disruption of
neurexin function after the completion of embryonic
and early postnatal development suggest that
functional impairment of mature circuits can trigger
autism-related phenotypes.
INTRODUCTION
Autism spectrum disorder (ASD) is a complex neurodevelop-
mental syndrome characterized by restricted and stereotyped
behavior patterns, difficulty with social interactions, and deficits
in verbal/nonverbal communication. ASD symptoms typically
emerge in early childhood and persist through adulthood, sug-
gesting ASD origin could stem from prenatal impairment that
develops into enduring postnatal manifestations. Alternatively,
dysfunction of postnatal neuronal networks at symptom onset
may define the clinical phenotype for this disorder. Thus, it
remains unclear whether there are early critical periods where
autism develops or if postnatal dysfunction of neuronal circuits
is sufficient to produce autism-related phenotypes.338 Cell Reports 8, 338–346, July 24, 2014 ª2014 The AuthorsThe neurexin family of synaptic plasma membrane proteins
forms one class of ASD-associated genes. Neurexins are en-
coded by three genes (NRXN1, NRXN2, and NRXN3), each of
which generates long a- and short b-neurexin proteins from
alternative promoters (Tabuchi and Su¨dhof, 2002; Ushkaryov
et al., 1992). Deletions and truncating mutations in the NRXN1
gene affecting a and b isoforms have been linked to autism
and other neurodevelopmental disorders (Ching et al., 2010;
Gauthier et al., 2011; Schaaf et al., 2012; Szatmari et al.,
2007). Moreover, point mutations specific to the NRXN1b
gene have been identified in ASD patients (Camacho-Garcia
et al., 2012, 2013). Neurexins couple presynaptic signaling
with binding to postsynaptic partners, such as neuroligins
(NLGNs) (Dean et al., 2003; Su¨dhof, 2008). The identification
of mutations in NLGN and SHANK genes in ASD pointed to glu-
tamatergic dysfunction of the NRNX-NLGN-SHANK pathway in
autism (Durand et al., 2007; Jamain et al., 2003; Laumonnier
et al., 2004).
Current genetic data support that hypofunction of neurexin
isoforms is a risk factor in autism. However, the brain regions
and the developmental stage in which loss of neurexin function
leads to autistic-like behaviors are not known. In rodents, neu-
rexin mRNAs are expressed throughout the developing and
mature CNS (Ehrmann et al., 2013; Iijima et al., 2011; Pu¨schel
and Betz, 1995), which raises the question of whether autism-
related symptoms can emerge from neurexin dysfunction after
the development has been completed. The manipulation of neu-
rexins is challenging because of their genetic complexity and
high number of isoforms (Treutlein et al., 2014). In multifactorial
disorders, such as ASD, a combination of DNA variants in a num-
ber of genes contributes to the clinical presentation. This poses
difficulties when the role of individual mutations is assessed in
animal models. Therefore, a dominant-negative approach is
well suited to address the effect of impaired neurexin function
in vivo. In this study, we generated transgenic mice that express
a neurexin-1bmutant in postnatal neurons of brain regions impli-
cated in autism, such as cortex and striatum (Parikshak et al.,
2013; Shepherd, 2013; Willsey et al., 2013). Neurexin-1bmutant
mice showed impaired glutamatergic transmission in pyramidal
cortical neurons and autism-related phenotype. Importantly,
the autism phenotype was reversed in young as well as older
mice upon inhibiting the expression of mutant neurexin-1b. Our
data indicate that neurexin dysfunction in postnatal forebrain
neurons recapitulates the core symptoms of autism, which can
be reversed in adult animals when normal neurexin function is
resumed.
RESULTS
Characterization of the Neurexin-1b Mutant Protein
Cytoplasmic-tail deletion mutants have been previously shown
to inhibit the synaptic function of neurexin variants in cultured
neurons (Choi et al., 2011; Dean et al., 2003; Futai et al., 2007).
The shared cytoplasmic tail of neurexins interacts with presyn-
aptic scaffolding proteins (Butz et al., 1998), whereas alternative
splicing at the extracellular domain modulates the binding to
postsynaptic partners, such that maximal binding to neuroligins
is exhibited by neurexin-1b variants lacking an insertion at splice
site 4 (-S4) (Boucard et al., 2005; Comoletti et al., 2006; Dean
et al., 2003). Thus, to uncouple neurexin-1b function, we gener-
ated a hemagglutinin (HA)-tagged deletion mutant of neurexin-
1b (-S4) that lacks the cytoplasmic tail (Figure 1A). First, we
analyzed the distribution of the HA-bnrx1DC protein, as it has
been suggested that C-terminal sequences are required for syn-
aptic targeting of neurexin-1a (Fairless et al., 2008). The cell-sur-
face localization of the HA-bnrx1DC protein was confirmed
in nonpermeabilized human embryonic kidney 293T (HEK293T)
cells (Figure S1A). Then, we studied the synaptic recruitment of
HA-bnrx1DC induced by neuroligin-1 (NL1) in nonneuronal cells
(Scheiffele et al., 2000). HA-bnrx1DC concentrated at synaptic
contacts mediated by VSV-NL1 at similar levels as wild-type
HA-bnrx1 (Figure 1B). The enrichment of the glutamatergic syn-
aptic vesicle marker vGluT1 to NL1 synapses was not affected
by the expression of HA-bnrx1DC (Figure 1B), indicating that
the cytoplasmic tail of neurexin-1b is dispensable for the recruit-
ment of synaptic vesicles, consistent with a recent report (Gokce
and Su¨dhof, 2013).
We reasoned that HA-bnrx1DC mutant might compete with
endogenous neurexins for the binding to postsynaptic partners
but affect other presynaptic parameters such as synapse func-
tion due to the absence of the cytoplasmic tail. Consistent with
this hypothesis, expression of a neurexin-1b mutant lacking the
cytoplasmic domain has previously been shown to decrease
release probability in hippocampal neurons, whereas overex-
pression of wild-type neurexin-1b had no effect (Futai et al.,
2007). To directly analyze the effect of HA-bnrx1DC mutant
on presynaptic release, we studied synaptic vesicle cycle
with sypHy (Granseth et al., 2006). We found that expression
of HA-bnrx1DC mutant in cultured hippocampal neurons
decreased action-potential-triggered sypHy fluorescence by
30%, whereas no effect was observed upon expression of
HA-bnrx1 (Figures 1C and S1B). These data indicated that dele-
tion of the intracellular domain of neurexin-1b does not inhibit
cell-surface localization or transsynaptic interactions with neuro-
ligins, but it decreases synaptic vesicle release.
Generation of bNrx1DC Mice
We used the HA-bnrx1DC mutant as a molecular tool to inhibit
neurexin function in postnatal neurons. With that purpose, we
generated transgenic mice that express HA-bnrx1DC in aninducible manner using the Tet-off system (Figure 1D). First,
we obtained a mouse line (TRE-HAbnrx1DC) that expresses
the HA-bnrx1DC transgene under the control of the tetracy-
cline-responsive promoter element (TRE). TRE-HAbnrx1DC
mice did not express HA-bnrx1DC protein in the brain, showing
no escape of the transgene (Figure 1E). It has been shown that
expression of neurexin-1 (-S4) transcripts is maximal in fore-
brain regions, including cortex (Ehrmann et al., 2013; Iijima
et al., 2011). Therefore, to direct the expression of HA-bnrx1DC
protein to forebrain neurons, we crossed TRE-HAbnrx1DCmice
with CaMKIIa-tTA mice that express the tetracycline trans-
activator (tTA) in postnatal glutamatergic neurons of the fore-
brain (Mayford et al., 1996). Double-transgenic CaMKIIa-tTA;
TRE-HAbnrx1DC mice (bNrx1DC mice) expressed HA-bnrx1DC
protein in forebrain neurons of the cortex and striatum and
showed no detectable expression in the midbrain and cere-
bellum (Figures 1E and 1F). Compared with endogenous neu-
rexin-1b, exogenous HA-bnrx1DC protein is expressed at
100%–200% in cortex and striatum (Figure 1F). Importantly,
expression of HA-bnrx1DC turns on only in the third postnatal
week (Figure 1G). Thus, in our mouse model, neurexin function
is unperturbed over the first 2 postnatal weeks when extensive
synapse formation takes place. Upon onset, HA-bnrx1DC
expression is maintained throughout adulthood (Figure 1G)
but can be suppressed by doxycycline (Dox) feeding of the
mutant mice (Figure 1H).
Synaptic Defects in bNrx1DC Mice
Neurexins have been proposed to participate in synapse forma-
tion and function by a presynaptic mechanism (Dean et al.,
2003; Missler et al., 2003). Therefore, an inhibitory effect in glu-
tamatergic synapses was predicted as a consequence of the
expression of the neurexin-1b mutant in cortical glutamatergic
neurons. Immunoblot experiments of cortical synaptosomes re-
vealed that HA-bnrx1DC is mostly expressed at presynaptic
fractions (Figures 2A and 2B), in agreement with a presynaptic
role of neurexin proteins. Because the expression of the neu-
rexin-1b mutant begins at a developmental stage when most
synapse formation has been completed but of active synaptic
plasticity, we analyzed the distribution of synaptic markers
and synaptic transmission in bNrx1DC mice. The expression
of selected synaptic proteins was not significantly altered in
bNrx1DC mice (Figures S2A and S2B). Then, we performed
whole-cell recordings in cortical layer 5/6 (L5/6) pyramidal
neurons of the somatosensory cortex, a region that expresses
relative high levels of the HA-bnrx1DC protein (Figure S2C).
The mean amplitude of miniature excitatory postsynaptic cur-
rents (mEPSCs) was not altered, suggesting normal quantal
content and postsynaptic apparatus. However, the frequency
of mEPSCs was reduced by50% in bNrx1DCmice (Figure 2C).
Analysis of the miniature inhibitory postsynaptic currents
(mIPSCs) in bNrx1DC mice showed a less significant reduc-
tion (30%) in the frequency, while the mIPSCs amplitude
was unchanged (Figure 2D). Consistent with the activity of
tTA in cortical glutamatergic neurons (Mayford et al., 1996),
GABAergic interneurons of the somatosensory cortex did not
express HA-bnrx1DC (Figure S2D), indicating that the reduction
in mIPSCs frequency likely reflects a compensatory mechanismCell Reports 8, 338–346, July 24, 2014 ª2014 The Authors 339
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Figure 1. bNrx1DC Mouse
(A) HA-tagged bnrx1 and bnrx1DC proteins. LNG, laminin/neurexin/sex hormone binding globulin domain; TM, transmembrane domain; cyto, cytoplasmic tail.
(B) Recruitment of HA-bnrx1 and HA-bnrx1DC to HEK293T cells expressing VSV-NL1. Hippocampal neurons infected with lentivirus expressing HA-bnrx1 or
HA-bnrx1DC and cocultured with HEK293T cells transfected with VSV-NL1 were immunostained with VSV (green), vGluT1 (red), and HA (blue) antibodies.
(C) Time kinetics (left graph) and peak amplitudes (right graph) of sypHy fluorescence elicited by 40, 100, and 300 action potentials in hippocampal neurons
cotransfectedwith sypHy and empty vector (control), HA-bnrx1, or HA-bnrx1DC. Average of >400 synapses obtained from 12 experiments from four independent
cultures.
(D) Experimental design of bNrx1DC mouse.
(E) Horizontal (top) and coronal (bottom) brain sections from control (TRE-HAbnrx1DC) and bNrx1DC mice (CaMKIIa-tTA; TRE-HAbnrx1DC) stained with HA
antibody. Cg, cingulate cortex; LEnt, lateral entorhinal; M, motor cortex; MEnt, medial entorhinal; PaS, parasubiculum; PrS, presubiculum; SS, somatosensory
cortex; STR, striatum.
(F) Immunoblots with HA and bNrx1 antibodies showing expression of HA-bnrx1DC and endogenous neurexin-1b proteins in lysates from cortex, striatum,
cerebellum, and hippocampal formation. The lower band recognized by the bnrx1 antibody represents exogenous HA-bnrx1DC. Graph shows quantitation of
HA-bnrx1DC expression normalized to endogenous bNrx1 (n = 3).
(G) Cortical lysates from control and bNrx1DC mice analyzed by immunoblotting with the HA antibody at the indicated postnatal time.
(H) Inhibition of HA-bnrx1DC expression in bNrx1DC mice fed with Dox.
Scale bars represent 5 mm in (B) and 500 mm in (E). *p < 0.05, **p < 0.01, ***p < 0.001. All error bars are SEM. See also Figure S1.to counterbalance decreased excitation (Lau and Murthy, 2012).
Moreover, the electrophysiological experiments indicate that
the reduced strength of glutamatergic transmission in bNrx1DC340 Cell Reports 8, 338–346, July 24, 2014 ª2014 The Authorsmice occurs by a presynaptic mechanism mediated by the
expression of the neurexin-1b mutant, providing a functional
validation of the genetic manipulation.
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Figure 2. Synaptic Defects in bNrx1DC Mice
(A) Cortical synaptosomes from control and
bNrx1DC mice immunoblotted with HA, vGluT1,
and PSD-95 antibodies, as indicated. L, lysate; SN,
supernatant; M, membrane; S, synaptosome; Pre,
presynaptic fraction; Post, postsynaptic fraction.
(B) Normalized HA-bnrx1DC expression in presyn-
aptic and postsynaptic fractions (n = 4).
(C and D) Representative traces and quantitations of
frequency and amplitude of mEPSCs (C) and
mIPSCs (D) recorded from L5/6 pyramidal neurons
of the somatosensory cortex. For mEPSCs: n = 9
cells from three control mice and n = 8 cells from
three bNrx1DC mice. For mIPSCs: n = 16 cells from
four control mice and n = 20 from four bNrx1DC
mice.
**p < 0.01, ***p < 0.001. All error bars are SEM. See
also Figure S2.Autistic-like Behavior of bNrx1DC Mice
We next analyzed the behavior of bNrx1DC mice. Body weight
and gross brain morphology were not affected in the bNrx1DC
mouse (Figure S3A and data not shown). In the rotarod test,
bNrx1DC mice displayed normal motor learning and did not
exhibit an anxiety-like phenotype in the open field (Figures 3A
and 3B). In the novel-object recognition test, the percentage of
time interacting with a novel object was similar in bNrx1DC and
control mice, although the total interaction time with any object
was significantly increased in bNrx1DC mice (Figure 3C).
To uncover autism-related symptoms, bNrx1DC mice were
compared with littermate controls using behavioral tests with
relevance in autism (Silverman et al., 2010). As deficits associ-
ated with autism appear early in life but persist through adult-
hood, we analyzed two cohorts of mice at different ages: young
(2–4 months old) and aged (7–9 months old) mice. Furthermore,
the analysis of two independent cohorts of mice offered an addi-
tional control for the behavioral studies.
Increased repetitive behavior and social impairment are symp-
toms of patients with autism. Interestingly, in the self-grooming
test young bNrx1DC mice showed increased repetitive pheno-
type compared to control mice (Figure 3D). Similarly, self-groom-
ing was also increased in aged bNrx1DCmice (Figure 4A). Social
behavior in mice can be analyzed in the three-chamber test
(Yang et al., 2011). In the sociability assay, the tested mouse
can freely move and interact with a caged object or mouse
placed in side chambers and the time in close interaction with
each stimulus is quantified. As expected, control mice interactedCell Reports 8, 338longer time with the mouse than with the
object (Figure 3E). Unlike control animals,
young bNrx1DC mice spent similar time
interacting with both stimuli, showing
increased interaction with the object and
decreased interaction with the mouse
(Figure 3E). This lack of preference for the
animated stimulus was also replicated
in aged bNrx1DC mice (Figure 4B). In the
social preference test, the object is re-
placed by a nonfamiliar mouse. While con-trol mice showed preferential interaction with the novel mouse,
young and aged bNrx1DC mice showed reduced interaction
with the novel mouse (Figures 3F and 4C). However, the number
of entries to each chamber and the traveled distance were
similar in control and bNrx1DC mice of both ages (Figures S3B
and S4A).
Deficits in communication are common in autistic patients.
In rodents, communication depends on olfactory cues. When
exposed to a novel odor, mice initiate sniffing and then habituate
to its novelty during repeated presentations. In the olfactory
habituation/dishabituation test, mice are exposed to sequential
presentations of nonsocial and social odors (Yang and Crawley,
2009). Control mice sniffed for a longer time a cotton swab
containing a social odor (urine A) than nonsocial odors (water,
vanilla, or orange blossom extracts) (Figures 3G and 4D). Inter-
estingly, in bNrx1DC mice, the time spent sniffing nonsocial
odors was increased to the level of the social odor (Figures 3G
and 4D). To rule out a general olfactory impairment, we analyzed
the time to find a buried food pellet and found no differences
between control and bNrx1DC mice (Figures S3C and S4B).
These data indicate that impaired neurexin function in late post-
natal forebrain neurons is sufficient to cause an autistic-like
phenotype that persists into adulthood.
Reversion of the Autistic-like Phenotype
The enduring behavioral deficits observed in bNrx1DC mice
could originate from a temporarily restricted effect during post-
natal development or rather from a continuous dysfunction of–346, July 24, 2014 ª2014 The Authors 341
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Figure 3. Increased Self-Grooming and Impaired Social Interaction and Preference for Social Odors in the bNrx1DC Mice
(A) Accelerating rotarod test. Data obtained from two trials per day during 4 consecutive days.
(B) Open field test. Locomotor activity (track length) and time in center were similar in control and bNrx1DC mice.
(C) Novel-object recognition test showed no differences in control and bNrx1DC mice in long-term memory index (LTM). Exploration index analysis resulted in
increased interaction time of bNrx1DC mouse.
(D) Increased time spent in self-grooming and number of bouts in bNrx1DC mice.
(E) Social interaction in the three-chamber test. Graph shows time in close interaction with a caged object or a mouse. bNrx1DC mice displayed similar time
interacting with a nonsocial (object) than with a social (mouse) stimulus.
(F) Analysis of social preference in the three-chamber test. bNrx1DC mice showed decreased interaction with a novel mouse.
(G) Olfaction habituation/dishabituation test. Quantitation of time spent sniffing a sequential presentation of nonsocial odors (water, orange blossom, and vanilla
extracts) and social odors (urine A and urine B).Whereas control mice displayed significantlymore time sniffing a social odor (urine A), bNrx1DCmice displayed no
difference among the first exposure to the tested odors.
(H–K) Control and bNrx1DCmice were fed with Dox for 14 days before re-evaluation of the behavioral phenotype. (H) Treatment with Dox reduced self-grooming
and frequency of bouts of bNrx1DC mice to control levels. (I) bNrx1DC mice treated with Dox showed preference for the animal versus the object in the
three-chamber sociability test. (J) Treatment with Dox increased the interaction of bNrx1DCmice with the novel mouse compared with the familiar mouse. (K) In
the olfaction habituation/dishabituation test, Dox-treated bNrx1DC mice showed increased time sniffing a social odor (urine A) compared to nonsocial odors.
n = 10–13 (A–C) and n = 9 (D–K) mice per genotype at 2–4 months of age.
*p < 0.05, **p < 0.01, ***p < 0.001. All error bars are SEM. See also Figure S3.adult neurons in the mature brain. In the former, inhibition of
transgene expression in mature bNrx1DC mice would fail to
rescue the behavioral deficits, which would be reversed, even342 Cell Reports 8, 338–346, July 24, 2014 ª2014 The Authorsin old mice, in the case that continuous dysfunction caused
the autistic-like phenotype of mutant mice. To distinguish
between these possibilities, we re-evaluated the behavioral
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Figure 4. Reversion of the Autistic-like Phenotype in Aged bNrx1DC Mice
(A) Time spent in self-grooming and frequency of bouts in aged control and bNrx1DC mice.
(B and C) In the three-chamber test, aged bNrx1DC mice showed similar time interacting with the mouse and the object (B) and with the novel and familiar
mouse (C).
(D) In the olfaction habituation/dishabituation test, bNrx1DC mice exhibited no preference for a social odor (urine A) compared with nonsocial odors.
(E–H) Reversion of the autistic-like phenotype in aged bNrx1DC mice. Analysis of self-grooming (E), sociability (F), social preference (G), and the olfaction
habituation/dishabituation test (H) in control and bNrx1DC mice after treatment with Dox. n = 10–13 mice per genotype. Mice were analyzed at 7–9 months and
re-evaluated at 9–11 months following treatment with Dox for 14 days.
*p < 0.05, **p < 0.01, ***p < 0.001. All error bars are SEM. See also Figure S4.phenotype after switching off transgene expression. A 2-week
treatment with Dox resulted in the effective inhibition of
HA-bnrx1DC expression in synaptosome fractions (Figure S4C).
Interestingly, the autism phenotype was reversed in young and
aged bNrx1DC mice after Dox treatment (Figures 3H–3K and
4E–4H). Self-grooming in bNrx1DC mice was reduced to control
levels after Dox treatment (Figures 3H and 4E). Notably, social
interaction deficits were recovered in bNrx1DC mice. In the
three-chamber test, Dox-treated bNrx1DC mice showed signif-
icant increased interaction with the mouse versus the object at
both tested ages (Figures 3I and 4F; Movies S1, S2, and S3).
Similarly, Dox treatment of young and aged bNrx1DC mice
increased the interaction with the novel mouse compared with
the familiar mouse (Figures 3J and 4G). In the olfactory habitu-
ation/dishabituation test, Dox-treated bNrx1DCmice decreased
the time spent sniffing nonsocial odors compared with the time
spent sniffing the social odor (Figures 3K and 4H), similar to the
pattern observed in control mice. However, Dox treatment had
no effect in control mice in any of the behavioral tasks (Figures 3
and 4). These data further confirmed that the behavioral deficits
observed in bNrx1DC mice are due to the expression of the
mutant HA-bnrx1DC protein rather than a positional effect of
the transgene. The reversion of the behavioral deficits indicated
that continuous absence of neurexin function in adult forebrainneurons leads to the autistic-like phenotype observed in
bNrx1DC mice.
DISCUSSION
Mutations in the NRXN1 gene have been increasingly found in
ASD patients. Although neurexin-1a knockout mice that show
autistic-related behaviors have been generated (Etherton et al.,
2009; Grayton et al., 2013), animal models for neurexin-1b had
not been reported. The data shown here further extends a role
for neurexin-1 proteins in autism. Behavioral analysis of the neu-
rexin-1b mutant mice uncovered increased repetitive behavior
and deficits in social interaction. In the three-chamber arena,
bNrx1DCmice presented defects in sociability and social prefer-
ence tests, shown as similar time interacting with an object and
a mouse and by a decreased interaction with a novel mouse,
respectively. Despite normal habituation/dishabituation and
detection of an olfactory cue (food pellet), bNrx1DC mice
showed similar response to social and nonsocial odors, reminis-
cent of the exaggerated response to sensory stimuli found in
ASD (Marco et al., 2011). The behavioral phenotype occurs in
the absence of deficits in locomotion and motor learning, anxi-
ety, and recognition memory, indicating that bNrx1DC mice
were not globally impaired. Although mutant neurexin-1b couldCell Reports 8, 338–346, July 24, 2014 ª2014 The Authors 343
be interacting with ligands shared by different neurexin isoforms,
these data support a role for synaptic dysfunction of neurexin-1b
in autism.
The rescue of ASD-associated symptoms in a number of
mouse models has challenged the irreversibility concept of
autism (Blundell et al., 2010; Gkogkas et al., 2013; Guy et al.,
2007; Pen˜agarikano et al., 2011; Won et al., 2012). However,
the developmental stagewhere perturbations of ASD-associated
genes lead to the onset of the autistic phenotype remains largely
unknown. The results shown here provide insight into the identi-
fication of the developmental period and the brain regions in
which dysfunction of neurexin produces a behavioral phenotype
associatedwith autism.Because of the restricted spatiotemporal
pattern of the geneticmanipulation, our data indicate that normal
neurexin function in adult forebrain neurons is critical to prevent
the onset of autistic-like behaviors in mice. Although most ASD
cases are sporadic, the identification of Mendelian syndromes
that display symptoms of autism has contributed to the elucida-
tion of the neurobiological basis of ASD. Interestingly, postnatal
mouse models of Mendelian ASD genes have been established
that recapitulate the core disease symptoms (Chen et al., 2001;
Kwon et al., 2006; McGraw et al., 2011; Tsai et al., 2012). The
neurexin-1b C-terminal deletion described here represents a
model of nonsyndromic autism, even though C-terminal dele-
tions reported so far in ASD patients also affect the transmem-
brane domain (Schaaf et al., 2012; Wisniowiecka-Kowalnik
et al., 2010). Together with the results described for Mendelian
ASD models, these findings would indicate the relevance in
ASD pathology of preserving normal function of ASD genes in
mature brain. The high prevalence of autism and the absence
of an effective treatment pose challenges for the care of patients
affected by this lifelong condition. Mutations in ASD-associated
genes are mostly found in heterozygosis, offering the stimula-
tion of the normal allele’s function as a potential therapeutic
approach. Our data showing reversion of the autistic-like pheno-
type in adult bNrx1DC mice indicate that autistic symptoms
arising from dysfunction of neurexinsmay benefit from therapeu-
tic interventions aimed to restore normal neurexin function, not
only during infancy but also in adult patients.EXPERIMENTAL PROCEDURES
Generation of Transgenic Mice
The HA-bnrx1DC construct contains an HA tag at the N terminus of the mature
protein and lacks the last 55 residues of the cytoplasmic tail. A DNA fragment
containing the TRE promoter, the coding sequence of HA-bNrx1DC and a
WPRE fragment (woodchuck hepatitis virus posttranscriptional regulatory
element) was injected into the pronucleus of FVB/N zygote for transgenic
mouse production. TRE-HAbnrx1DC mice were backcrossed with C57BL/6J
mice for four generations followed by mating with CaMKIIa-tTA mice in a
C57BL/6J background (Mayford et al., 1996) that led to the generation of
bNrx1DC mice (CaMKIIa-tTA/TRE-HAbnrx1DC). Animals were kept at 22C
on a 12 hr dark/light cycle and food and water were provided ad libitum. In
some experiments, Dox (SAFE) was provided in the diet (0.625 g/kg). Mice
were used according to animal care standards and all protocolswere approved
by theCommitteeofAnimalUse forResearchat theUniversity ofSeville (Spain).
Behavioral Analysis
Behavioral studies were performed in two independent cohorts of male
bNrx1DC and littermate control mice of different ages: 2–4 months (young344 Cell Reports 8, 338–346, July 24, 2014 ª2014 The Authorsmice) and 7–11 months (aged mice). To avoid any effect due to the insertion
of the transgene, littermate TRE-HAbnrx1DCmice were included in the control
population along with nontransgenic littermates. In rescue experiments, con-
trol and bNrx1DC mice were fed with Dox for 2 weeks. To eliminate memory
effects on the behavioral tasks, the initiation of treatment with Dox in aged
mice was delayed for 2 months (age at the re-evaluation time, 9–11 months).
All behavioral tasks and quantitation analysis were performed by researchers
blind to the genotype of the mice.
Electrophysiology
Whole-cell patch-clamp recordings were performed in coronal slices of post-
natal day 27 (P27) to P32 control and bNrx1DC mice. mIPSCs and mEPSCs
were recorded from L5/6 pyramidal neurons of the somatosensorial cortex.
The recordings and analysis of the electrophysiological experiments were
performed by a researcher blind to the genotype.
Statistical Analysis
Student’s t test was used for comparisons between two groups. One-way
ANOVA was used in the analysis of live imaging in cultured hippocampal
neurons. Two-way repeated-measures ANOVA with Bonferroni’s post hoc
comparison was performed in the rotarod, three-chamber, and olfaction
habituation/dishabituation tests. Data were analyzed using SPSS 13.0
(IBM) and Prism5 software (GraphPad Software). All data are shown as
mean ± SEM.
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